Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Scholarly review .

Target-Based Drug Discovery: Discovery and Synthesis of G-Protein Biased Agonists Towards the 5-Hydroxytryptamine2A Receptor

View Full Paper
Ask AI
Bookmark
Share

Authors

ALAndrew J. Long

Discussion

Loading...

Member takes

Overview

This review discusses biased agonism and screening methodologies for 5-HT2A receptor agonists, suggesting new treatment avenues.

Key Points

  • Lead candidates (R)-69 and (R)-70 show potential for treating neuropsychiatric disorders through biased agonism.
  • The study emphasizes the importance of pharmacokinetics and pharmacodynamics in drug efficacy and safety evaluations.
  • Novel agonists inspired by psychoactive compounds can harness therapeutic benefits without hallucinogenic effects.
  • Screening methodologies highlight the role of structural motifs, particularly nitrogen heterocycles, in drug design.

Cite This Study

Andrew J. Long (2025) studied this question.

synapsesocial.com/papers/68bb4e016d6d5674bcd02a5bhttps://doi.org/10.70121/001c.143864
View Full Paper
Ask AI
Bookmark
Share